Menta Capital’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,237
Closed -$499K 630
2018
Q4
$499K Sell
4,237
-3,200
-43% -$370K 0.19% 156
2018
Q3
$897K Buy
7,437
+4,387
+144% +$544K 0.31% 65
2018
Q2
$352K Sell
3,050
-4,268
-58% -$467K 0.08% 430
2018
Q1
$629K Buy
+7,318
New +$567K 0.13% 287
2017
Q4
Sell
-6,074
Closed -$350K 821
2017
Q3
$350K Sell
6,074
-21,320
-78% -$1.26M 0.05% 585
2017
Q2
$1.76M Sell
27,394
-15,593
-36% -$961K 0.21% 157
2017
Q1
$2.48M Buy
42,987
+12,107
+39% +$723K 0.24% 124
2016
Q4
$1.89M Sell
30,880
-944
-3% -$61.5K 0.16% 206
2016
Q3
$2.2M Sell
31,824
-9,480
-23% -$625K 0.21% 150
2016
Q2
$2.3M Buy
41,304
+31,628
+327% +$1.91M 0.32% 41
2016
Q1
$587K Sell
9,676
-1,200
-11% -$70.6K 0.08% 422
2015
Q4
$695K Sell
10,876
-10,060
-48% -$652K 0.09% 383
2015
Q3
$1.4M Buy
20,936
+2,254
+12% +$159K 0.22% 141
2015
Q2
$1.28M Sell
18,682
-16,046
-46% -$1.02M 0.21% 184
2015
Q1
$1.93M Buy
+34,728
New +$1.78M 0.25% 134
2014
Q4
Sell
-21,400
Closed -$788K 745
2014
Q3
$788K Buy
+21,400
New +$772K 0.13% 246
2014
Q1
Sell
-5,600
Closed -$212K 451
2013
Q4
$212K Buy
+5,600
New +$214K 0.09% 297

Other funds holding USNA

Menta Capital's USNA Position: Q1 2019 in Review

Menta Capital sold out of Usana Health Sciences (USNA) in Q1 2019, closing a stake of 4,237 shares — an estimated $499K sold.

Menta Capital first reported a position in USNA in Q4 2013 and held it in 17 quarters. The position peaked at $2.48M in Q1 2017. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

  • Menta Capital reported no remaining Usana Health Sciences position as of Q1 2019 after selling out during the quarter.
  • Menta Capital sold 4,237 Usana Health Sciences shares in Q1 2019, an estimated $499K.
  • Menta Capital first reported a position in Usana Health Sciences in Q4 2013 and held it in 17 quarters.
  • Menta Capital's Usana Health Sciences position peaked at $2.48M in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on Menta Capital's 13F filing for Q1 2019, filed 1 May 2019.